Marc Erickson
Danville, PANPI 1265939268
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (46.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Medtronic at 59.9% of the total. 2025 is the largest year on record at $13,122, more than ten times the $28 reported in 2021.
Across 122 payments — averaging $175.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$13K
- Boston Scientific$3K
- Biotronik Inc.$3K
- Abbott$802
- Biosense Webster, Inc.$679
- E.r. Squibb & Sons, L.L.C.$346
- plus $1K from 12 others
What the payments were for
- Grants$10,00047%
- Travel & lodging$4,52721%
- Food & beverage$6,30329%
- Education$5813%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 22 | $12,819 |
| Boston Scientific | 18 | $2,965 |
| Biotronik Inc. | 24 | $2,664 |
| Abbott | 9 | $802 |
| Biosense Webster, Inc. | 7 | $679 |
| E.r. Squibb & Sons, L.L.C. | 4 | $346 |
| Boehringer Ingelheim | 7 | $230 |
| Abiomed | 7 | $210 |
| Sanofi-aventis U.S. LLC | 4 | $142 |
| Shockwave Medical, Inc | 1 | $130 |
| Edwards Lifesciences | 1 | $103 |
| Pfizer | 4 | $77 |
| AstraZeneca(2 entities) | 5 | $72 |
| Merck | 3 | $48 |
| Lantheus Medical Imaging, Inc. | 2 | $47 |
| Lexicon Pharmaceuticals, Inc. | 2 | $35 |
| Cardiva Medical, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 30 | $318 |
| Rosuvastatin Calcium | 15 | $189 |
| Losartan Potassium | 15 | $101 |
| Atorvastatin Calcium | 12 | $53 |
| Spironolactone | 20 | $42 |
| Carvedilol | 14 | $41 |
| Amlodipine Besylate | 15 | $41 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.